Tubal obstruction with an implant inserted by hysteroscopy: a report of 50 cases
Saad-Ganem, A.; Alanis-Fuentes, Jé.; López-Ortiz, C.Gerardo.Salazar.; Muradas-Gil, Lía.; Quintero-Bernal, P.; Palma-Dorantes, J.; Charua Levy, Eías.
Ginecologia y Obstetricia de Mexico 82(7): 448-453
2014
ISSN/ISBN: 0300-9041 PMID: 25102670 Document Number: 624234
The Essure contraceptive device consists of a titanium and nickel coiled spring containing Dacron fibers. It is placed under hysteroscopic visualizaron in the proximal section of the Fallopian tube. The microinsert acts by inducing a tissue reaction that permanently blocks the tube within three months. Show our experience in the use and insertion of the Essure device, in a private office. We reviewed insertion procedure, complications, degree of tolerance and acceptance by user. Between June 2008 and May 2013 fifty cases with Essure placement were made in our office. The average age was 36 years, as for the average number of pregnancies was two. The procedure time average was 6 minutes 25 seconds, no intraoperative complication was reported. All patients expressed very good tolerance and high degree of satisfaction with the procedure. A simple abdominal radiography was performed three months after the hysteroscopy to dem6nstrate the correct placement and position of the device, in all patients. The number of patients is enough to show the advantages of the method and the possibility of performing it in an ambulatory environment, as it can be a private office with the correct equipment to do it.